Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2025

Apr 23, 2025

34519_dirs_2025-04-23_00d251e8-23d4-48f6-92d7-91471261b453.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-04-16

Reporting Person: Fiori Timothy C (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-16 Incentive Stock Options (Right to buy) $5.49 A 30000 Acquired 2035-04-16 Common Stock (30000) Direct